Octanoic acid
Octanoic acid is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target hydroxycarboxylic acid receptor 3 and cytochrome P450 4Z1.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
34 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic inflammatory demyelinating polyradiculoneuropathy | D020277 | EFO_1000868 | G61.81 | — | — | 1 | — | — | 1 |
| Wiskott-aldrich syndrome | D014923 | D82.0 | — | — | 1 | — | — | 1 | |
| Severe combined immunodeficiency | D016511 | D81.0 | — | — | 1 | — | — | 1 | |
| Immunologic deficiency syndromes | D007153 | HP_0002721 | D84.9 | — | — | 1 | — | — | 1 |
| Agammaglobulinemia | D000361 | D80.1 | — | — | 1 | — | — | 1 | |
| Common variable immunodeficiency | D017074 | EFO_0000367 | D83 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Essential tremor | D020329 | EFO_0003108 | G25.0 | 3 | 2 | — | — | — | 3 |
| Human influenza | D007251 | EFO_0007328 | J11.1 | 1 | 2 | — | — | — | 2 |
| Myeloid leukemia acute | D015470 | C92.0 | 1 | 2 | — | — | — | 2 | |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | — | — | 1 | 2 |
| Hepatocellular carcinoma | D006528 | C22.0 | — | 2 | — | — | — | 2 | |
| Non-small-cell lung carcinoma | D002289 | 1 | 1 | — | — | — | 1 | ||
| Myeloid sarcoma | D023981 | C92.3 | — | 1 | — | — | — | 1 | |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | — | 1 | — | — | — | 1 |
| Myelodysplastic syndromes | D009190 | D46 | — | 1 | — | — | — | 1 | |
| Cholangiocarcinoma | D018281 | C22.1 | 1 | 1 | — | — | — | 1 |
Show 4 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic ductal carcinoma | D021441 | 2 | — | — | — | — | 2 | ||
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | — | — | — | — | 2 |
| Acinar cell carcinoma | D018267 | 2 | — | — | — | — | 2 | ||
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 2 | — | — | — | — | 2 | |
| Biphenotypic leukemia acute | D015456 | C95.0 | 2 | — | — | — | — | 2 | |
| Healthy volunteers/patients | — | 1 | — | — | — | 1 | 2 | ||
| Non-hodgkin lymphoma | D008228 | C85.9 | 1 | — | — | — | — | 1 | |
| B-cell chronic lymphocytic leukemia | D015451 | C91.1 | 1 | — | — | — | — | 1 | |
| B-cell lymphoma marginal zone | D018442 | C88.4 | 1 | — | — | — | — | 1 | |
| Follicular lymphoma | D008224 | C82 | 1 | — | — | — | — | 1 |
Show 19 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastric emptying | D005746 | — | — | — | — | 1 | 1 | ||
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
| Child nutrition disorders | D015362 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | OCTANOIC ACID |
| INN | octanoic acid |
| Description | Octanoic acid is a straight-chain saturated fatty acid that is heptane in which one of the hydrogens of a terminal methyl group has been replaced by a carboxy group. Octanoic acid is also known as caprylic acid. It has a role as an antibacterial agent, a human metabolite and an Escherichia coli metabolite. It is a straight-chain saturated fatty acid and a medium-chain fatty acid. It is a conjugate acid of an octanoate. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CCCCCCCC(=O)O |
Identifiers
| PDB | — |
| CAS-ID | 124-07-2 |
| RxCUI | 20178 |
| ChEMBL ID | CHEMBL324846 |
| ChEBI ID | 28837 |
| PubChem CID | 379 |
| DrugBank | DB04519 |
| UNII ID | OBL58JN025 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
HCAR3
HCAR3
CYP4Z1
CYP4Z1
Organism
Homo sapiens
Gene name
HCAR3
Gene synonyms
GPR109B, HCA3, HM74B, NIACR2
NCBI Gene ID
Protein name
hydroxycarboxylic acid receptor 3
Protein synonyms
G-protein coupled receptor 109B, G-protein coupled receptor HM74, G-protein coupled receptor HM74B, GTP-binding protein, hydroxy-carboxylic acid receptor 3, Niacin receptor 2, Nicotinic acid receptor 2, putative chemokine receptor
Uniprot ID
Mouse ortholog
—
—
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 6,535 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more